Patients with intestinal malabsorption may develop cardiac dysfunction the origin of which is often unclear. We sought to investigate the pathogenesis of dilated cardiomyopathy in human malabsorption.
Introduction
Chronic intestinal malabsorption is frequently associated with disorders of cardiac rhythm and function. Although various mechanisms such as chronic anaemia, autoimmune myocarditis, 1 absorption of bacterial toxins, and loss of essential nutrients have been advocated, very often the specific pathogenetic link remains unknown. Even histological and ultrastructural analysis of myocardial tissue can be inconclusive, often showing degenerative non-specific changes. In this context the search for myocardial viral genomes by polymerase chain reaction (PCR) as well as the assessment of myocardial trace elements by instrumental neutron activation analysis (INAA) can be highly informative. In fact myocardial viral infection has an increased prevalence in patients with intestinal malabsorption, 2 while deprivation of trace elements such as selenium (Se) loss can induce a progressive heart muscle disease indistinguishable from idiopathic dilated cardiomyopathy. 3, 4 In addition, Se and zinc (Zn) deficiency has been found to impair the immune system, increasing viral genome virulence and patients' susceptibility to infectious diseases. 5 -7 Nevertheless, there is no study in the literature conducting a systematic evaluation of myocardial micronutrients in patients with chronic intestinal malabsorption and cardiomyopathy, andactual knowledge is confined to rare case reports analysing single trace elements. 8, 9 Even less it is known about the mechanism through which deprivation of Se or other trace elementcan cause myocardial damage. Conversely, identification of the cause and mechanism of cardiomyopathy has practical implications since Se administration has been shown to revert the cardiac dysfunction associated with Keshan disease. 9, 10 The aim of the present study was to analyse the structural changes and the possible mechanism of damage in dilated cardiomyopathy occurring in patients with chronic intestinal malabsorption. Preliminary results of Se/Zn administration are also reported.
Methods

Patient population
From January 1998 to December 2008 in our institution 1233 consecutive white Italian patients (666 males and 567 females, mean age 46.5 + 15.8 years) were admitted because of chronic (≥6 months) unexplained left ventricular (LV) dilatation and dysfunction unresponsive to antiheart failure therapy including digitalis, furosemide, enalapril, and carvedilol for ≥ 3 months. Among them, 32 patients had intestinal malabsorption due to intestinal bypass because of severe obesity. Eighteen of these patients (time from intervention 12.5 + 2.2 years) gave their consent for an invasive study and constituted our patient population (group A). No patient had hypertension, drug or alcohol abuse, ischaemic heart disease, or systemic disorders. No skeletal muscle and/or additional systemic symptoms were present.
Cardiac studies
All patients underwent both non-invasive and invasive cardiac studies including LV endomyocardial biopsy, performed using a Bipal bioptome (Cordis Corporation, NJ, USA).
The LV approach was preferred to the right ventricular approach in order to minimize sampling error as the right ventricle usually appeared normal or barely affected. Four to six LV samples were drawn, processed for histology, immunohistochemistry, and electron microscopy, and the results were read by a pathologist blinded to the clinical data. 11 Additional samples were snap-frozen in liquid nitrogen for molecular biology studies, trace element assessment, LC3 protein evaluation, and determination of glutathione peroxidase (GPX) activity. LV endomyocardial biopsies from 15 sex-and agematched patients with idiopathic dilated cardiomyopathy, no myocardial viral genomes or histological evidence of inflammation, with a comparable degree of LV compromise were used as controls. Additional non-dilated cardiomyopathy controls were papillary muscle surgical biopsies from 15 sex-and age-matched patients with mitral stenosis and normal LV undergoing mitral valve replacement. The latter endomyocardial fragments, although not obtained from healthy individuals, were derived from a non-overloaded chamber and were considered the nearest samples to a normal endomyocardial tissue. 12 Blood samples were collected from patients and controls, and stored at -808C as whole blood, serum, and plasma samples. The study project received approval from our Ethics Committee.
Histopathological studies
Multiple 5 mm thick sections were stained with haematoxylin-eosin, Miller's elastic Van Gieson, and Masson's trichrome, and examined by light microscopy. In all patients, immunohistochemistry for the characterization of inflammatory infiltrates (CD45, CD43, CD45RO, CD20, CD68, CD4, and CD8) was performed. The presence of apoptotic cardiomyocytes was evaluated by means of in situ ligation of hairpin probes with single-base 3 ′ overhangs. 13 Morphometry using a grid and point counting system with 42 sampling points 11 
LC3 protein assessment
Autophagy is an intracellular degradation process that is characterized by the formation of double-membrane vesicles, known as autophagosomes, which sequester cytoplasm. It has been shown to be involved in cell growth, survival, development, and death, and its dysregulation has been linked to many human pathologies, including heart diseases. In mammalian cells, autophagy is a largely unknown process, and only recently mammalian homologues of yeast genes have been discovered and used as molecular markers for autophagy. LC3, one of the homologues of yeast ATG8, is modified during the autophagic process. The C-terminal region of LC3 is cleaved, generating a soluble form known as LC3-I, which, in turn, is lipidated, generating an LC3 -phospolipid conjugate (LC3-II). LC3-II localizes to autophagosomes and autolysosome membranes. Therefore, the amount of LC3-II in mammalian cells is regarded as a good marker for the formation of autophagosomes. 14 Thus, we used this marker to test and quantify the induction of the autophagic process in the myocardium of patients with idiopathic and malabsorption-associated cardiomyopathy (see Supplementary material online).
Molecular biology studies
PCR and reverse transcription -PCR (RT -PCR) analysis was performed on two frozen endomyocardial tissue samples to search for the most common DNA and RNA cardiotropic viruses as described. 15 
Assessment of myocardial trace elements
The metal content of biopsies and sera was determined by INAA. 16 The following elements were analysed: silver (Ag), arsenic (As), gold (Au), barium (Ba), calcium (Ca), cadmium (Cd), cerium (Ce), cobalt (Co), chromium (Cr), caesium (Cs), europium (Eu), iron (Fe), hafnium (Hf), mercury (Hg), iridium (Ir), lanthanum (La), lutetium (Lu), molybdenum (Mo), nickel (Ni), rubidium (Rb), antimony (Sb), scandium (Sc), selenium (Se), samarium (Sm), tin (Sn), strontium (Sr), tantalum (Ta), terbium (Tb), thorium (th), uranium (U), ytterbium (Yb), zinc (Zn), and zirconium (Zr).
The detailed methodology is reported in the Supplementary material online.
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Determination of glutathione peroxidase activity
Se-dependent GPX activity was measured spectrophotometrically in myocardial tissue following the decrease in absorbance at 340 nm, using H 2 O 2 as substrate. 17 Data are expressed as nanomoles of NADPH consumed per minute per milligram of protein.
Treatment and follow-up
Patients with malabsorption who were prepared to undergo an invasive follow-up including a control endomyocardial biopsy were treated with Se/Zn infusion (Addamel N 10 mL i.v. corresponding to Se 300 mg and Zn 13.6 mg every day for 1 week and every week for 6 months) in addition to chronic (.6 months) supportive therapy including digitalis, diuretics, angiotensin-converting enzyme (ACE) inhibitors, and carvedilol (group A1, n ¼ 10). Eight patients who declined an additional invasive study were treated only with antiheart failure therapy (group A2, n ¼ 8) and constitute our control population. Clinical assessment, resting electrocardiogram (ECG) and two-dimensional echocardiography were performed at baseline, weekly during the first month, and every 4 weeks for the remaining 5 months. In all members of group A1, cardiac catheterization, angiography, and endomyocardial biopsy were performed at 6 months. The New York Heart Association (NYHA) class was used to assess functional capacity and was determined by means of a questionnaire. Echocardiographic studies were performed with an Agilent Sonos 5500 (Hewlett-Packard, Palo Alto, CA, USA). Patients were imaged and data were analysed offline by a single senior echocardiographer blinded to the treatment groups. Echocardiographic parameters were determined according to established criteria. In particular, the ejection fraction (EF) was calculated in the apical four-and twochamber views from three separate cardiac cycles using the modified Simpson's method. probability test (in the case of two-by-two contingency tables with an expected cell count of ,5). In the case of multiple comparison, Bonferroni's correction was applied to control the experimental type I error probability. Changes of variables before and after treatment were analysed with the paired t-test or the signed rank test in the case of non-normality. A two-tailed P-value ≤ 0.05 was considered statistically significant.
Statistical analysis
Results
Patient population and cardiac studies
No cases of occupational exposure to trace elements were observed, not did any patient or control subject come a from heavily polluted geographic area. None had a recent history of a flu-like syndrome. Coronary angiography was normal in all. Clinical and echocardiographic data of the 18 patients and comparison among the three groups are shown in Table 1 .
Histological, morphometric, and ultrastructural analysis
Histology of LV biopsy fragments from each patient ruled out specific heart muscle diseases such as myocarditis, and storage or infiltrative heart muscle diseases, whereas signs of hypertrophy with attenuation and degenerative changes of myocardial fibres were seen ( Figure 1) . No distinctive histological changes were observed between those with idiopathic dilated cardiomyopathy and malabsorption-associated cardiomyopathy ( Table 1 ). In particular the total fibrosis, including the replacement, interstitial, and perivascular components, was increased, being represented mainly by the replacement type in both groups compared with controls ( Figure 1) . The endocardium was thickened because of increased fibrous tissue and hypertrophy and proliferation of smooth muscle cells (Figure 1 ). Electron microscopy showed degenerative changes to consist of loss of contractile elements, the presence of myelin bodies, and vacuolization of mitochondria with fragmentation of mitochondrial cristae in both groups ( Figure 2) . However, in patients with malabsorption-associated cardiomyopathy, remarkable evidence of cell autophagy was also detected (Figure 3) . Apoptosis was increased to a degree comparable with those with idiopathic dilated cardiomyopathy (see Table 1 ). The presence of a consistent amount of myocardial fibrosis suggests necrosis to have an appreciable role in malabsorption cardiomyopathy.
LC3 protein assessment
LC3 assessment showed an accumulation of LC3-II in patients with dilated cardiomyopathy due to malabsorption, whereas samples from control patients or from patients with idiopathic dilated cardiomyopathy showed a lower amount of LC3-II ( Figure 2 ).
Molecular biology studies
In all patients with malabsorption and with idiopathic dilated cardiomyopathy, as well as the controls, PCR and RT-PCR were negative for the presence of myocardial virus infection.
Assessment of myocardial trace elements
Patients with malabsorption showed a remarkable decrease in myocardial and serum Se and Zn concentration ( Table 1) . The results for the remaining detectable trace elements are listed in Table 2 .
Glutathione peroxidise activity
Reduced myocardial GPX activity was evident in patients with malabsorption vs. both those with idiopathic dilated cardiomyopathy and normal controls ( Table 2) .
Treatment and follow-up
After 6 months of treatment, a normalization of serum Se/Zn levels ( Table 3 ) was observed in group A1, accompanied by a reduction in heart rate, an enhancement in QRS voltages, and improvement of repolarization abnormalities. These changes were associated with an improvement in at least one NYHA class, a reduction in LV enddiastolic diameter, and an increase in LV EF (Table 3) . Conversely, in group A2, serum Se/Zn levels, ECG findings, and LV dimensions and function remained unchanged ( Table 3) . In all group A1 patients after 6 months of treatment an improvement in degenerative changes, consisting of a reduction in cardiomyocyte vacuoles due to an increase in myofibrillar content, remarkable reduction of autophagic bodies (Figure 1) , reduction in LC3-II levels, and significant increase in myocardial Se and Zn content and GPX activity, was observed ( Table 3) .
Discussion
Dilated cardiomyopathy is a clinical entity characterized by progressive cardiac dilatation and dysfunction which may involve various aetiologies and mechanisms of damage. 18 Cardiomyopathy associated with intestinal malabsorption has been variously attributed to chronic anaemia, autoimmune myocarditis, absorption of bacterial toxins, and loss of essential nutrients. 19 In our study, neither remarkable anaemia ( haemoglobin ,10 g/ dL), nor myocarditis, nor detectable viral genomes were observed, while hypertrophy with degeneration and death of cardiomyocytes was associated with myocardial deficiency of Se and Zn at INAA of LV endomyocardial biopsies. Se and Zn were similarly low in the homologous serum samples; however, in accordance with previous reports, 8, 20 cardiomyopathy was not associated with skeletal muscle and/or additional systemic symptoms.
Instrumental neutron activation analysis and myocardial trace elements
INAA has been shown to be the most advantageous method for quantitative determination of trace elements in human tissues owing to its high level of precision, high specificity, and high accuracy. 21 In our study a remarkable reduction of myocardial and serum Se and Zn content was shown in patients with cardiomyopathy and intestinal malabsorption in comparison with subjects with idiopathic dilated cardiomyopathy and normal controls.
Selenium/zinc loss and myocardial antioxidant reserve
Se and Zn are incorporated in the active site of several human enzymes. In particular, Zn is an essential component of nearly 100 enzymes where it exerts a catalytic, structural, and regulatory function. 7 Its deficiency may impair gene expression and hormonal release, compromising grow and development; it may depress the immune system and favour cell apoptosis and necrosis. Se has its own mRNA codon that specifies its insertion into proteins as selenocysteine. Selenocysteine, the 21st physiologically essential amino acid, is present at the active site of all known Se-dependent enzymes where its unique redox potential facilitates their biochemical function. Se deficiency has been associated with the development of a progressive dilated cardiomyopathy (Keshan disease) and an impairment of the immune system increasing viral genome virulence and patients' susceptibility to infections. At the cardiac level, Zn and Se are essential for the activity of copper-zinc superoxide dismutase and GPX, respectively, enzymes that play a major role in the detoxification of cardiomyocytes from free radicals. Deficiency of both trace elements may, therefore, result in a compromise of the antioxidant property of the heart, with oxidative damage of the cell membrane and a decline of cardiac function.
In our patients, myocardial Se deficiency was accompanied by a significant reduction in GPX activity. Myocardial and serum Se were not extremely low but were significantly lower than in patients with idiopathic dilated cardiomyopathy and in controls, and were accompanied by structural changes consistent with oxidative damage. On the other hand, it is already known that there is no definite relationship between serum concentration and GPX activity. Similarly, superoxide dismutase, not tested in this study because of shortage of tissue, could have been compromised as a result of Zn deprivation con tributing to oxidative cell damage.
Zn is also a structural component of metalloproteinases and its deficiency may have played a part in jeopardizing the extracellular matrix contributing to the development of cardiac dilatation and dysfunction.
The elective cardiac involvement of Se/Zn deficiency, already reported in previous studies, 8 -20 could be explained by the low antioxidant reserve of the heart, averaging 1% of that expressed by the liver, and the compulsory activity of the heart compared with the intermittent and voluntary activity of the skeletal muscles.
Structural changes in selenium/ zinc-deficient cardiomyopathy
Histology, immunohistochemistry, and electron microscopy showed no evidence of myocarditis, or of specific endomyocardial lesions. Hypertrophy with remarkable degeneration of myocardiocytes, presenting myofibrillolysis and enhanced cell apoptosis and autophagy, were the main morphological abnormalities and were associated with cell necrosis as suggested by extensive areas of replacement fibrosis. In particular, the presence of autophagosomes was a pronounced and widespread phenomenon that was absent in control samples and focally detectable in patients with idiopathic dilated cardiomyopathy of similar severity. Cell autophagy was associated with elevation of LC3-II, a protein that is generated by autophagosome membranes and is, therefore, considered a reliable marker. 14 In accordance with the ultrastructural features, LC3-II was much less expressed in both idiopathic dilated cardiomyopathy and control biopsies. Summarizing, the observed structural changes, although not strictly specific, are consistent with oxidative damage of cell membranes as well as reduction of GPX activity. These changes, together with a reduction of myocardial GPX activity, provide new insights into the pathogenetic mechanism of Se-and Zn-deficient cardiomyopathy.
In addition, the presence of extensive areas of myocardial fibrosis suggests an additional oxidative stress-mediated cell necrosis and may explain the incomplete recovery of cardiac function registered in our study as in other studies. 9 Response to selenium/zinc infusion Group A1 receiving a Se/Zn infusion showed a clear improvement of LV dimension and function compared with group A2 who failed to improve when receiving supportive therapy alone. Clinical improvement in group A1 was paralleled by normalization of myocardial Se/Zn and GPX activity, with striking amelioration of cardiomyocyte degenerative changes including a remarkable reduction of cell autophagy and myofibrillolysis.
Practical implications
Due to the close correlation observed between myocardial and serum trace element levels, the identification of Se and Ze deficiency can be achieved through analysis of the peripheral blood and evaluation of GPX activity in the red blood cells. Appropriate blood checking and supplementation with Se and Zn may prevent the establishment of a progressive cardiomyopathy in patients with intestinal malabsorption.
Finally Se/ Zn-deficient cardiomyopathy should be included in the American Heart Association (AHA) definition and classification of cardiomyopathies 22 as a potentially reversible myocardial disease, and American College of Cardiology (ACC)/AHA guidelines on endomyocardial biopsy 23 should consider malabsorption cardiomyopathy as a possible indication for a biopsy study.
Limitation of the study
Despite the fact that the effects of Se/Zn infusion on malabsorption cardiomyopathy appear clinically and histologically appreciable, some study limitations need to be mentioned. In particular: (i) the retrospective nature of the study design; (ii) the low number of patients enrolled with obvious consequences on statistical significance; and (iii) the type of control group that does not represent a healthy control population. It could be argued that myocardial Se and Zn deficiency might derive from expansion of myocardial fibrous tissue which eventually become poorer in terms of trace element content. Indeed myocardial volume composition was similar in the cohort of idiopathic and malabsorption-associated cardiomyopathy, suggesting cardiomyocyte deprivation of Se and Zn in the malabsorption group.
Conclusions
An Se-/Zn-deficient cardiomyopathy may occur in patients with chronic intestinal malabsorption. It is characterized by decline of myocardial antioxidant reserve with oxidative damage of the cell membrane and enhanced cell death.
Se and Zn infusion may improve and probably prevent the malabsorption-associated cardiomyopathy. A prospective randomized placebo-controlled trial is desirable to confirm these preliminary results.
Supplementary material
Supplementary material is available at European Journal of Heart Failure online.
